That's a wrap.
Market opens Friday, Nov 13 at 9:30 AM ET
7:13 AMYahoo Finance
Halozyme Therapeutics (HALO) stock gets fair value boost after Q3 analyst revisions
6:12 AMYahoo Finance
Halozyme Therapeutics (HALO) stock looks in Line as ENHANZE approval Lands
11:11 AMYahoo Finance
Will HALO's partner royalties drive growth for the Rest of 2026?
2:42 PMYahoo Finance
Halozyme Therapeutics (HALO) is an Incredible growth stock: 3 reasons why
8:40 AMYahoo Finance
Are Medical stocks Lagging Halozyme Therapeutics (HALO) this year?
6:49 AMYahoo Finance
HALO Q3 2026 deep dive: royalty expansion and next-gen platform investments drive outlook update
10:04 AMYahoo Finance
Halozyme Reaffirms it Projects Zero to minimal impact to royalty revenue through at Least 2035 based on Medicare Drug price Negotiation Program Final rule for IPAY 2029
9:57 AMYahoo Finance
U.S. FDA approves RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) Co-Formulated with Halozyme's ENHANZE® Technology for the treatment of advanced head and Neck Cancer
12:14 AMYahoo Finance
What Halozyme Therapeutics (HALO) said on its Q3 earnings call
6:29 PMYahoo Finance
Halozyme falls 6% as raised guidance fails to impress investors
4:10 PMYahoo Finance
Halozyme Therapeutics (NASDAQ:HALO) surprises with Q3 2026 sales but stock drops
4:05 PMYahoo Finance
HALOZYME REPORTS THIRD QUARTER 2026 RESULTS AND RAISES FULL YEAR 2026 FINANCIAL GUIDANCE